PODD

280.96

1.15% -3.27

Handel nachbörslich: 280.96

Insulet Corporation (PODD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PODD? Forum Prognose

Schlusskurs vom Vortag:

$284.23

Offen:

$284.655

24-Stunden-Volumen:

376.48K

Relative Volume:

0.47

Marktkapitalisierung:

$19.77B

Einnahmen:

$2.20B

Nettoeinkommen (Verlust:

$402.20M

KGV:

50.53

EPS:

5.56

Netto-Cashflow:

$280.80M

1W Leistung:

-3.78%

1M Leistung:

-7.32%

6M Leistung:

+1.77%

1J Leistung:

+44.06%

1-Tages-Spanne:

$280.43

$288.00

1-Wochen-Bereich:

$280.43

$293.17

52-Wochen-Spanne:

$173.00

$329.33

Insulet Corporation Stock (PODD) Company Profile

Firmenname

Insulet Corporation

Sektor

Healthcare (1161)

Branche

Medical Devices (147)

Telefon

978-600-7000

Adresse

100 NAGOG PARK, ACTON, MA

Mitarbeiter

3,900

Twitter

@insulet_uk

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PODD's Discussions on Twitter

Vergleichen Sie PODD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PODD Insulet Corporation	280.96	20.55B	2.20B	402.20M	280.80M	5.56
ABT Abbott Laboratories	124.42	229.71B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	103.78	154.35B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	387.32	149.60B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	89.70	114.97B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.56	45.92B	5.54B	4.18B	623.10M	7.00

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-16	Eingeleitet	Truist	Buy
2025-05-30	Eingeleitet	Goldman	Buy
2025-05-13	Hochstufung	Wolfe Research	Peer Perform → Outperform
2025-04-29	Herabstufung	Wolfe Research	Outperform → Peer Perform
2025-03-06	Eingeleitet	RBC Capital Mkts	Outperform
2024-11-06	Eingeleitet	Bernstein	Outperform
2024-05-30	Eingeleitet	Redburn Atlantic	Buy
2024-05-07	Hochstufung	Wolfe Research	Peer Perform → Outperform
2023-12-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2023-12-04	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Hochstufung	Jefferies	Hold → Buy
2023-08-21	Hochstufung	Citigroup	Neutral → Buy
2023-08-21	Herabstufung	Robert W. Baird	Outperform → Neutral
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-04	Hochstufung	Piper Sandler	Neutral → Overweight
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-03	Hochstufung	BTIG Research	Neutral → Buy
2022-02-02	Hochstufung	UBS	Neutral → Buy
2022-01-31	Hochstufung	Oppenheimer	Perform → Outperform
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-01	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Hochstufung	Canaccord Genuity	Hold → Buy
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-07-28	Eingeleitet	Wells Fargo	Overweight
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Eingeleitet	BofA/Merrill	Neutral
2020-03-31	Herabstufung	Berenberg	Buy → Hold
2020-03-05	Eingeleitet	Citigroup	Buy
2019-12-10	Eingeleitet	CFRA	Sell
2019-10-23	Eingeleitet	Stifel	Hold
2019-10-18	Herabstufung	Canaccord Genuity	Buy → Hold
2019-10-14	Herabstufung	BTIG Research	Buy → Neutral
2019-10-04	Herabstufung	UBS	Buy → Neutral
2019-10-03	Herabstufung	Guggenheim	Buy → Neutral
2019-08-06	Hochstufung	JP Morgan	Neutral → Overweight
2019-06-10	Herabstufung	Northland Capital	Outperform → Market Perform
2019-05-06	Hochstufung	BTIG Research	Neutral → Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-02-22	Bestätigt	Barclays	Overweight
2018-01-08	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-11-03	Hochstufung	Canaccord Genuity	Hold → Buy
2017-09-15	Eingeleitet	Barclays	Overweight

Alle ansehen

Insulet Corporation Aktie (PODD) Neueste Nachrichten

06:30 AM

Is Insulet Corporation a good long term investmentHigh-yield market plays - Autocar Professional

06:30 AM

04:45 AM

What analysts say about Insulet Corporation stockBreakout stock performance - Autocar Professional

04:45 AM

07:05 AM

Digital Diabetes Management Market is projected to reach US$ - openPR.com

07:05 AM

Jul 20, 2025

Insulet Corporation Stock Analysis and ForecastTremendous return on equity - Autocar Professional

Jul 20, 2025

What drives Insulet Corporation stock priceOutstanding risk-reward balance - Autocar Professional

Jul 20, 2025

Jul 17, 2025

$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today - Benzinga

Jul 17, 2025

Navigating the Crossroads: Insulet's Short-Term Volatility and Long-Term Growth Potential - AInvest

Jul 17, 2025

Jul 11, 2025

Insulet's PODD Stock Plunges 2.72% Amid Market Uncertainty - AInvest

Jul 11, 2025

Jul 10, 2025

Smart Pumps Market is projected to reach USD 19.96 billion by 2033 - openPR.com

Jul 10, 2025

Jul 09, 2025

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 09, 2025

Jul 08, 2025

Leading Insulin Pump Maker Insulet to Release Q2 2025 Results August 7Key Details for Investors - Stock Titan

Jul 08, 2025

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire

Jul 08, 2025

Jul 07, 2025

Trading (PODD) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 07, 2025

Jul 06, 2025

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? - MSN

Jul 06, 2025

Jun 30, 2025

5 Insightful Analyst Questions From Insulet’s Q1 Earnings Call - Yahoo Finance

Jun 30, 2025

Jun 26, 2025

Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech

Jun 26, 2025

Jun 25, 2025

Insulet Stock Plummets 30.61% with $196M Trading Volume Ranking 493rd Amid Omnipod 5 Recall - AInvest

Jun 25, 2025

Jun 24, 2025

How Is Insulet's Stock Performance Compared To Other Medical Devices Stocks? - Barchart.com

Jun 24, 2025

Jun 23, 2025

Insulet’s Eric Benjamin shares update on automated insulin delivery system - MedTech Dive

Jun 23, 2025

Jun 19, 2025

5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions - Business Wire

Jun 19, 2025

Jun 17, 2025

Truist bullish on diabetes companies citing potential market growth - MSN

Jun 17, 2025

Insulet’s SWOT analysis: patch pump leader’s stock poised for growth By Investing.com - Investing.com South Africa

Jun 17, 2025

Insulet’s SWOT analysis: patch pump leader’s stock poised for growth - Investing.com

Jun 17, 2025

Jun 16, 2025

Analyst Predicts Strong Growth for Insulet (PODD) with Buy Ratin - GuruFocus

Jun 16, 2025

Insider Sell: Dan Manea Sells 1,300 Shares of Insulet Corp (PODD) - GuruFocus

Jun 16, 2025

Insulet, EyePoint & NanoDx receive $2M in tax incentives to create life sciences jobs - Worcester Business Journal

Jun 16, 2025

Insulet (PODD) Rated 'Buy' by Truist Securities; Price Target Set at $365 | PODD Stock News - GuruFocus

Jun 16, 2025

(PODD) Investment Report - news.stocktradersdaily.com

Jun 16, 2025

Truist initiates Insulet stock with buy rating on diabetes pump potential - Investing.com Nigeria

Jun 16, 2025

Truist Initiates Insulet at Buy With $365 Price Target - MarketScreener

Jun 16, 2025

Truist Securities Starts Insulet Corporation (PODD) at Buy - StreetInsider

Jun 16, 2025

Jun 13, 2025

Insulet’s SWOT analysis: pump maker’s stock rides wave of growth By Investing.com - Investing.com South Africa

Jun 13, 2025

Insulet’s SWOT analysis: pump maker’s stock rides wave of growth - Investing.com

Jun 13, 2025

Trade secret misappropriation: permanent injunction and monetary damages - Reuters

Jun 13, 2025

Here's Why You Should Retain PODD Stock in Your Portfolio Now - MSN

Jun 13, 2025

Jun 12, 2025